Search results for "CANNABIS"

showing 10 items of 174 documents

The Stigmatization of Drug Addiction in South-East Turkey the Case of Drug Abuse Prevention Programme for Youth Project in Turkey

2022

Cannabis use undergoes a dynamic redefinition under selected legal frameworks globally. Many prevention programs face a dilemma between delivering abstinence objectives and pursuing more nuanced, harm reductionist aims. However, drug use in South-East Turkey is strongly stigmatized and is absent from the official life of the community, so neither of these discussions takes place. The authors participated in the development of a Drug Abuse Prevention programme for Youth and this article is grounded in qualitative data from Turkey. A follow-up study was conducted among the youth participants of a pilot phase of the program (n = 20), developed by an international group of professionals in the …

familypreventionTurkeystigmatizationCannabisAddicta-The Turkish Journal on Addictions
researchProduct

Fattori di rischio ambientale ed esordio psicotico: dati preliminari su un campione di pazienti siciliani

2011

first episode cannabis eventi stressanti
researchProduct

analisi dei punteggi PANSS in un campione di pazienti affetti da psicosi

2010

first episode cannabis pattern psicopatologici
researchProduct

Vietējās kaņepju šķirnes „Pūriņi” augu ploiditātes un genotipu atšķirības molekulāro marķieru un eļļas specifisko īpašību nosakošo gēnu līmenī

2015

Sējas kaņepes (Cannabis sativ, L.) ir lauksaimniecībā nozīmīgs kultūraugs. Eiropas Savienības valstīs, arī Latvijā strauji pieaug interese par kaņepju audzēšanu. Pašlaik Latvijā nav savas sējas kaņepju šķirnes, kas būtu piemērotas sēklu iegūšanai. Jaunu šķirņu ātrākai iegūšanai ļoti nozīmīgas ir in vitro metodes, molekulāro metodžu izmantošana un iekļaušana selekcijas shēmā, tādēļ šim darbam ir sekojošs mērķis: vietējo kaņepju ‘Pūriņi’ in vitro kultivēšana, augu ģenētiskās daudzveidības un ploiditātes noteikšana, metilēšanas noteikšanas metodes izstrāde Δ12 un Δ15 desaturāzes gēnam. Veicot molekulāri ģenētisko analīzi izmantojot iPBS metodi konstatēts, ka vietējās kaņepes ‘Puriņi’ populācij…

in vitro pavairošanaMetilēšanas analīzeSējas kaņepesCannabis sativa L.BioloģijaĢenētiska daudzveidība
researchProduct

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Human.

2013

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognit…

lcsh:MedicineNeuropsychological TestsSocial and Behavioral SciencesPrefrontal cortexReceptores de cannabinoides:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Executive FunctionEndocrinologyCognitionWisconsin Card Sorting TestEndocrinologiaHuman PerformanceMedicinePsychologyendocannabinoid systemPrefrontal cortexlcsh:ScienceProblem SolvingPsychiatryMultidisciplinaryCognitive NeurologyCognitive flexibilityPresa de decisionsCognitionMiddle AgedExecutive functionsexecutive functionsHumanos2-arachidonoylglycerolSubstance abuseEndocannabinoidesMental HealthNeurologyCognicióMedicineFemalelipids (amino acids peptides and proteins):Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors G-Protein-Coupled::Receptors Cannabinoid [Medical Subject Headings]Animal behaviorClinical psychology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Arachidonic Acids [Medical Subject Headings]HumanResearch ArticleAdultN-arachidonoylethanolamine:Psychiatry and Psychology::Mental Disorders::Substance-Related Disorders::Marijuana Abuse [Medical Subject Headings]Polyunsaturated AlkamidesCognitive NeuroscienceDecision MakingArachidonic AcidsGlyceridesYoung AdultCannabinoides -- ReceptorsNeuropsychologyCànnabis:Diseases::Nervous System Diseases::Neurodegenerative Diseases [Medical Subject Headings]Pruebas neuropsicológicasÁcidos araquidónicosHumansFunción ejecutivaBiologyCannabisCannabinoides -- Efectes fisiològics:Anatomy::Nervous System::Central Nervous System [Medical Subject Headings]Behavior:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoids [Medical Subject Headings]business.industrylcsh:RCognitive Psychologymedicine.diseaseIowa gambling taskEnfermedades neurodegenerativasAbuso de marihuanaSistema nervioso central:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Executive Function [Medical Subject Headings]lcsh:QbusinessDecision makingStroop effectNeuroscienceEndocannabinoids
researchProduct

Eventi di vita stressanti in un campione di pazienti affetti da psicosi all’esordio: prevalenza, sintomatologia ed età d’esordio

2011

Introduzione: Un consistente numero di studi suggerisce un’elevata prevalenza di eventi traumatici nella storia di soggetti con disturbi psicotici (Shevlin et al, 2008). Piu’ che l’impatto di un singolo evento di vita stressante, l’esposizione cumulativa ad esperienze traumatiche sembra incrementare il rischio di psicosi (van Winkel et al, 2008). Scopo dello studio e’ valutare la prevalenza di tali eventi in soggetti al primo episodio psicotico a confronto con controlli sani e la possibile correlazione con la sintomatologia psicotica e l’età di esordio. Metodologia: In atto sono stati reclutati 74 soggetti al primo episodio psicotico (51 m, 23 f; em=26.39, ds=9.36) e 27 controlli sani (18 m…

life events first episode cannabis
researchProduct

CB1 Cannabinoid Receptors and Aggression

2016

Abstract The relation between the use of cannabis and violent behavior is controversial, partly owing to the complexity of the concept of aggression and variability among the studies performed. The primary psychoactive compound of cannabis, Δ9-tetrahydrocannabinol, acts on G-protein-coupled receptors such as the cannabinoid type 1 (CB1) receptor, the most important of the endocannabinoid system. Although historically suspected of instigating aggressive behaviors, the findings of research about cannabis use in humans are mixed. While cannabis intoxication seems to reduce the likelihood of violence, mounting evidence associates withdrawal with an increase in aggression. Acute or chronic canna…

medicine.medical_specialtyCannabinoid receptorbiologybusiness.industryAggressionmedicine.medical_treatmentCannabis usebiology.organism_classificationEndocannabinoid systemDiscontinuationMedicineCannabisAnimal studiesCannabinoidmedicine.symptombusinessPsychiatry
researchProduct

Associations between parenting and substance use, meal pattern and food choices: A cross-sectional survey of 13,269 Norwegian adolescents

2019

Identifying factors that affect adolescent lifestyle behaviors is essential in order to develop effective generic prevention approaches. This study aimed to investigate the association between parental monitoring, parental emotional support, parental-adolescent conflict and adolescent substance use, meal pattern and food choices. The study included data from 13,269 Norwegian adolescents aged 13–16 years collected in 2016. Multivariable logistic regression models adjusted for gender, age and parental education were applied. Results show that low parental monitoring was associated with increased substance use (Odds ratios (OR) ranging from 2.8; 95% Confidence intervals (CI) 2.1–3.6 to OR 3.8;…

medicine.medical_specialtyCross-sectional studyPsychological interventionlcsh:Medicine030209 endocrinology & metabolismHealth InformaticsNorwegianDiet food and nutritionLogistic regression03 medical and health sciences0302 clinical medicineEnvironmental healthFood choiceMedicine030212 general & internal medicineMealsCannabisParentingbiologybusiness.industryPublic healthlcsh:RSmokingPublic Health Environmental and Occupational HealthRegular ArticleOdds ratioAdolescent alcohol useVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850biology.organism_classificationlanguage.human_languagelanguageCannabisbusinessPreventive Medicine Reports
researchProduct

Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany

2016

Cognitive Enhancement (CE) is often discussed in relation to stimulant drugs, such as amphetamines (AMPH). However, there is some evidence that cannabis (CAN) can be used for CE.This study compares the knowledge, prevalence, and perceived effects of and factors associated with the knowledge of or use of CAN versus AMPH for CE among undergraduate students at four German universities.A survey was taken of 1,538 students at four German universities. It investigated their knowledge and use of CAN and AMPH for CE as well as associated factors. Descriptive and analytic (Mann-Whitney-U test, Fisher's exact test, logistic regression) statistics were obtained using SPSS.Responses were obtained from …

medicine.medical_specialtyHealth (social science)UniversitiesLifetime prevalenceMedicine (miscellaneous)Logistic regressionGerman03 medical and health sciencesCognition0302 clinical medicineGermanySurveys and QuestionnairesAdaptation PsychologicalmedicineHumans030212 general & internal medicineStudentsPsychiatryCannabisbiologyPublic Health Environmental and Occupational HealthCognitionbiology.organism_classificationlanguage.human_language030227 psychiatryTest (assessment)Psychiatry and Mental healthExact testlanguageCannabisPsychologySubstance Use & Misuse
researchProduct

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort

2017

BACKGROUND AND AIMS: Few data exist on changes to substance use patterns before and after hepatitis C virus (HCV) treatment. We used longitudinal data of HIV-HCV co-infected individuals to examine whether receiving pegylated interferon (Peg-IFN)-based therapy irrespective of HCV clearance could modify tobacco, cannabis and alcohol use. DESIGN: A prospective cohort of HIV-HCV co-infected individuals was enrolled from 2006. Participants' clinical data were retrieved from medical records and socio-demographic and behavioural characteristics were collected by yearly self-administered questionnaires. SETTING: Data were collected across 17 hospitals in France. PARTICIPANTS: All HIV-HCV co-infecte…

medicine.medical_specialtyHepatitis C virusMedicine (miscellaneous)Binge drinkingmedicine.disease_causeUnit of alcohol03 medical and health sciences0302 clinical medicinePegylated interferonInternal medicinemedicine030212 general & internal medicineProspective cohort studybiologybusiness.industryvirus diseasesHepatitis Cmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthPsychiatry and Mental healthCohort030211 gastroenterology & hepatologyCannabisbusinessmedicine.drugAddiction
researchProduct